Stoke Therapeutics, Inc.
STOK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001623526
In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Stoke Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 99
- +5 vs. Q4 2021
- Shares held
- 41.4M
- +5.91M (+16.7%) vs. Q4 2021
- Total value
- $870.6M
- +$21.0M (+2.5%) vs. Q4 2021
- New holders
- 20
- 36 more added
- Sold out
- 15
- 27 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STOK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 197 | $2.49B |
| Q1 2026 | 198 | $2.31B |
| Q4 2025 | 183 | $2.13B |
| Q3 2025 | 151 | $1.57B |
| Q2 2025 | 134 | $744.0M |
| Q1 2025 | 126 | $421.6M |
| Q4 2024 | 130 | $640.4M |
| Q3 2024 | 118 | $715.5M |
| Q2 2024 | 115 | $828.5M |
| Q1 2024 | 103 | $731.7M |
| Q4 2023 | 81 | $236.9M |
| Q3 2023 | 97 | $173.1M |
| Q2 2023 | 100 | $494.8M |
| Q1 2023 | 97 | $371.8M |
| Q4 2022 | 107 | $371.8M |
| Q3 2022 | 105 | $544.4M |
| Q2 2022 | 92 | $569.4M |
| Q1 2022 | 99 | $870.6M |
| Q4 2021 | 94 | $849.6M |
| Q3 2021 | 90 | $492.4M |
| Q2 2021 | 97 | $680.3M |
| Q1 2021 | 106 | $1.49B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Stoke Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −233,997−100.0% | Sold out |
| Casdin Capital, LLC | 0 | $0 | 0.00% | −120,000−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −82,407−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −22,480−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,057−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −13,313−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −10,065−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −9,346−100.0% | Sold out |
| Erste Asset Management GmbH | 0 | $0 | 0.00% | −9,200−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −901−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −750−100.0% | Sold out |
| HM Payson & Co | 0 | $0 | 0.00% | −99−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Westwood Wealth Management | 0 | $0 | 0.00% | −95−100.0% | Sold out |